Deniz Gökalp

Prof. Deniz Gökalp is a dedicated endocrinologist with a strong clinical and academic background. He completed his professorship at Acıbadem Eskişehir Hospital in 2016 and has been an active member of the Acıbadem Health Group since 2015. His work focuses on diabetes and metabolic disorders, combining patient care with ongoing professional development. He holds memberships in key national organizations, including the Turkish Diabetes Foundation, the Turkish Medical Association, and the Turkish Society of Endocrinology and Metabolism, reflecting his commitment to advancing diabetes care and endocrine health in Turkey.

Education

• 2016 Acibadem Eskisehir Hospital / Professor Doctor
• 2010 – 2012 Sivas Numune Hospital / Compulsory Service / Associate Professor Doctor
• 2009 Dicle University Faculty of Medicine Endocrinology and Metabolic Diseases
• 2005 Dicle University Faculty of Medicine Internal Medicine
• 1999 Dokuz Eylul University Faculty of Medicine

Experience

• 2015 Acibadem Health Group
• 2013 – 2015 Memorial Dicle Hospital / Associate Professor Doctor
• 2012 – 2013 Private Seyrantepe Hospital / Associate Professor Doctor
• 2006 – 2010 Dicle University Faculty of Medicine
• 2008 – 2009 Harvard Medical School. / A.B.D / Endocrine Fellow
• 2005 – 2009 Dicle University Faculty of Medicine Endocrinology / Specialist Doctor
• 2001 – 2005 Dicle University Faculty of Medicine Internal Medicine / Research Assistant
• 1999 – 2000 Derik State Hospital / General Practitioner

Memberships

• Turkish Diabetes Foundation
• Turkish Medical Association
• Turkish Society of Endocrinology and Metabolism

Publications

• Four decades without diagnosis:Sheehan’s syndrome, a retrospective analysis.
  Gynecol Endocrinol. 2016 Jun 2:1-4. Gokalp D, Alpagat G, Tuzcu A, Bahceci M, Tuzcu S, Yakut F, Yildirim A.
• Postprandial hyperlipidemia in overt and subclinical hypothyroidism.
  Eur J Intern Med. 2012 Sep;23(6):e141-5. Arikan S, Bahceci M, Tuzcu A, Celik F, Gokalp D.
• Insulin resistance in Type 2 Diabetes Mellitus May Be Related to Bone Mineral Density
  J Clin Densitom. J Clin Densitom. 2012 Apr-Jun;15(2):186-90. Arikan S, Tuzcu A, Bahceci M, Ozmen S, Gokalp D.
• Predictive value of serum NT-proBNP levels in type 2 diabetic people with diabetic nephropathy.
  Diabetes Res Clin Pract. 2012 Mar;95(3):312-6. Danis R, Ozmen S, Arikan S, Gokalp D, Alyan O.
• Massive Metformin Overdose in Two Subjects with Suicidal Behavior?: Brief Communication
  Turkiye Klinikleri J Med Sci 2012;32(2):559-62. Şenay ARIKAN, Alpaslan TUZCU, Mithat BAHÇECİ, Mehmet Ali KAPLAN, Deniz GÖKALP.
• p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis.
  Nature Medicine. 2011 Sep 4;17(10):1251-60. Lee J, Sun C, Zhou Y, Lee J, Gokalp D, Herrema H, Park SW, Davis RJ, Ozcan U
• The Prevalence of Celiac Disease in Patients with Diabetes Mellitus
  International Journal of Clinical Medicine, 2011, 2, 201-205. Deniz Gökalp, Senay Arıkan, Mustafa Yakut, Yekta Tüzün, Alparslan Kemal Tuzcu, Mithat Bahçeci, İrfan Soykan.
• Assessment of Thyroid Function in Children Aged 1-13 Years with Beta-Thalassemia Major
  Iran J Pediatr 2011;21:77-823. Pirinccioglu AG, Deniz T, Gokalp D, Beyazit N, Haspolat K, Soker M.
• Assessment of bleeding disorders in Sheehan’s syndrome: are bleeding disorders the underlying cause of Sheehan’s syndrome?
  Platelets. 2011;22(2):92-7. Gokalp D, Tuzcu A, Bahceci M, Ayyildiz O, Erdemoglu M, Alpagat G.
• Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia.
  Clin Biochem. 2010 Oct;43(15):1220-4. Pirinccioglu AG, Gokalp D, Pirinccioglu M, Kizil G, Kizil M.